J. B. Chemicals & Pharmaceuticals Limited
NSE:JBCHEPHARM.NS
1638.1 (INR) • At close July 4, 2025
Overview | Financials
Numbers are in millions (except for per share data and ratios) INR.
| 2025 Q4 | 2025 Q3 | 2025 Q2 | 2025 Q1 | 2024 Q4 | 2024 Q3 | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 Q3 | 2023 Q2 | 2023 Q1 | 2022 Q4 | 2022 Q3 | 2022 Q2 | 2022 Q1 | 2021 Q4 | 2021 Q3 | 2021 Q2 | 2021 Q1 | 2020 Q4 | 2020 Q3 | 2020 Q2 | 2020 Q1 | 2019 Q4 | 2019 Q3 | 2019 Q2 | 2019 Q1 | 2018 Q1 | 2017 Q4 | 2016 Q4 | 2014 Q1 | 2013 Q1 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue
| 9,494.8 | 9,634.9 | 10,006.2 | 10,044 | 8,617.3 | 8,445.1 | 8,817.4 | 8,962 | 7,623.2 | 7,927.1 | 8,094.4 | 7,848.1 | 6,245.876 | 6,006.56 | 5,930.117 | 6,059.885 | 4,917.811 | 5,482.169 | 4,435.643 | 5,222.85 | 4,115.448 | 4,286.325 | 4,564.17 | 4,461.103 | 3,859.489 | 3,820.262 | 4,353.426 | 3,659.717 | 2,838.378 | 3,062.619 | 3,027.591 | 2,291.667 | 1,848.471 |
| Cost of Revenue
| 3,216.4 | 3,167.4 | 5,508.7 | 5,474.4 | 4,937.2 | 2,736.3 | 2,981.7 | 3,099.7 | -5,091.2 | 2,990.1 | 3,015.5 | 2,927.8 | 2,332.653 | 2,060.32 | 2,075.346 | 2,165.426 | 2,104.605 | 1,868.909 | 1,338.288 | 1,862.557 | 1,704.67 | 1,503.478 | 1,667.056 | 1,667.486 | 1,888.317 | 1,263.884 | 1,595.129 | 1,315.988 | 1,112.15 | 1,132.567 | 1,113.786 | 985.701 | 788.411 |
| Gross Profit
| 6,278.4 | 6,467.5 | 4,497.5 | 4,569.6 | 3,680.1 | 5,708.8 | 5,835.7 | 5,862.3 | 12,714.4 | 4,937 | 5,078.9 | 4,920.3 | 3,913.223 | 3,946.24 | 3,854.771 | 3,894.459 | 2,813.206 | 3,613.26 | 3,097.355 | 3,360.293 | 2,410.778 | 2,782.847 | 2,897.114 | 2,793.617 | 1,971.172 | 2,556.378 | 2,758.297 | 2,343.729 | 1,726.228 | 1,930.052 | 1,913.805 | 1,305.966 | 1,060.06 |
| Gross Profit Ratio
| 0.661 | 0.671 | 0.449 | 0.455 | 0.427 | 0.676 | 0.662 | 0.654 | 1.668 | 0.623 | 0.627 | 0.627 | 0.627 | 0.657 | 0.65 | 0.643 | 0.572 | 0.659 | 0.698 | 0.643 | 0.586 | 0.649 | 0.635 | 0.626 | 0.511 | 0.669 | 0.634 | 0.64 | 0.608 | 0.63 | 0.632 | 0.57 | 0.573 |
| Reseach & Development Expenses
| 0 | 0 | 0 | 0 | 305.635 | 0 | 0 | 0 | 319.328 | 0 | 0 | 0 | 291.07 | 0 | 0 | 0 | 235.341 | 0 | 0 | 0 | 193.861 | 0 | 0 | 0 | 238.847 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| General & Administrative Expenses
| 0 | 0 | 0 | 0 | 29.122 | 0 | 0 | 0 | 74.122 | 0 | 0 | 0 | 1,182.694 | 0 | 0 | 0 | 400.499 | 0 | 0 | 0 | 867.866 | 0 | 0 | 0 | 867.708 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Selling & Marketing Expenses
| 0 | 0 | 0 | 0 | 2,077.178 | 0 | 0 | 0 | 1,807.778 | 0 | 0 | 0 | 1,249.587 | 0 | 0 | 0 | 838.212 | 0 | 0 | 0 | 826.561 | 0 | 0 | 0 | 817.929 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| SG&A
| 1,768.2 | 0 | 2,211.1 | 2,173.7 | 2,106.3 | 1,960.8 | 1,917.5 | 1,487.5 | 1,881.9 | 1,806 | 1,876.9 | 1,338.7 | 2,432.281 | 1,194.706 | 1,054.031 | 1,276.238 | 1,238.711 | 846.983 | 810.714 | 886.66 | 1,694.427 | 823.158 | 770.217 | 780.541 | 1,685.637 | 722.587 | 737.51 | 674.64 | 0 | 0 | 0 | 0 | 0 |
| Other Expenses
| 0 | 4,341.8 | 0 | 58.9 | 166.3 | 73.5 | 76.6 | 56.3 | 45.8 | 31.3 | 13.4 | 8.9 | -363.07 | 45.278 | 196.441 | 129.742 | -457.31 | 222.659 | 83.927 | 226.896 | -407.121 | 163.796 | 185.085 | 126.08 | -233.393 | 158.203 | 85.526 | 11.172 | 92.718 | 1,457.722 | 1,259.986 | 15.152 | 27.001 |
| Operating Expenses
| 1,768.2 | 4,341.8 | 2,211.1 | 2,173.7 | 2,106.3 | 3,817.9 | 3,722 | 3,855 | 3,556.2 | 3,473.3 | 3,514.4 | 3,453.5 | 2,847.052 | 2,834.854 | 2,744.693 | 2,436.125 | 1,782.638 | 2,077.256 | 2,170.828 | 1,979.02 | 1,600.212 | 2,054.371 | 2,058.367 | 1,991.805 | 1,350.325 | 1,923.203 | 2,090.186 | 1,747.366 | 1,558.835 | 1,457.722 | 1,259.986 | 976.726 | 830.785 |
| Operating Income
| 4,510.2 | 2,125.7 | 2,286.4 | 2,395.9 | 1,573.8 | 1,964.4 | 2,190.3 | 2,007.3 | 22,784 | 1,495 | 1,577.9 | 1,466.8 | 1,059.167 | 1,111.386 | 1,110.078 | 1,458.334 | 1,052.877 | 1,536.004 | 926.527 | 1,381.273 | 852.214 | 728.476 | 838.747 | 801.812 | 621.779 | 633.175 | 668.111 | 596.363 | 260.111 | 474.735 | 632.839 | 328.882 | 139.683 |
| Operating Income Ratio
| 0.475 | 0.221 | 0.228 | 0.239 | 0.183 | 0.233 | 0.248 | 0.224 | 2.989 | 0.189 | 0.195 | 0.187 | 0.17 | 0.185 | 0.187 | 0.241 | 0.214 | 0.28 | 0.209 | 0.264 | 0.207 | 0.17 | 0.184 | 0.18 | 0.161 | 0.166 | 0.153 | 0.163 | 0.092 | 0.155 | 0.209 | 0.144 | 0.076 |
| Total Other Income Expenses Net
| -2,579.9 | 54.2 | 78.9 | 2.5 | 72.2 | -51.4 | -103.7 | -64.3 | 21,899.979 | -51.7 | -66.2 | -49.4 | -26.355 | 31.866 | 184.196 | 120.348 | 289.653 | 548.615 | 66.77 | 189.444 | -140.331 | 155.264 | 176.346 | 118.043 | 61.983 | 145.232 | 77.883 | 1.372 | -7.912 | 0 | 0 | -53.952 | -81.589 |
| Income Before Tax
| 1,930.3 | 2,179.9 | 2,365.3 | 2,398.4 | 1,646 | 1,839.5 | 2,086.6 | 1,943 | 23,322.9 | 1,412 | 1,498.3 | 1,417.4 | 1,032.812 | 1,143.252 | 1,294.274 | 1,578.682 | 1,320.221 | 2,084.619 | 993.297 | 1,570.717 | 670.235 | 883.74 | 1,015.093 | 919.855 | 682.83 | 778.407 | 745.994 | 594.812 | 252.199 | 474.735 | 632.839 | 274.93 | 58.094 |
| Income Before Tax Ratio
| 0.203 | 0.226 | 0.236 | 0.239 | 0.191 | 0.218 | 0.237 | 0.217 | 3.059 | 0.178 | 0.185 | 0.181 | 0.165 | 0.19 | 0.218 | 0.261 | 0.268 | 0.38 | 0.224 | 0.301 | 0.163 | 0.206 | 0.222 | 0.206 | 0.177 | 0.204 | 0.171 | 0.163 | 0.089 | 0.155 | 0.209 | 0.12 | 0.031 |
| Income Tax Expense
| 473.4 | 555 | 619.6 | 630.1 | 384.4 | 503.8 | 580.7 | 519.8 | -210.8 | 351 | 387.5 | 365.4 | 183.069 | 302.078 | 315.398 | 388.088 | 312.12 | 541.779 | 254.062 | 375.663 | 169.526 | 219.272 | 77.462 | 298.742 | 214.927 | 278.894 | 231.281 | 174.107 | 48.526 | 53.244 | 127.479 | 71.676 | 15.009 |
| Net Income
| 1,456.9 | 1,624.9 | 1,745.7 | 1,768.3 | 1,261.578 | 1,335.7 | 1,505.9 | 1,423.2 | 876.2 | 1,061 | 1,110.8 | 1,050.3 | 848.451 | 838.86 | 977.531 | 1,188.732 | 1,006.126 | 1,541.066 | 738.228 | 1,194.216 | 501.393 | 662.772 | 936.241 | 620.05 | 466.571 | 498.549 | 513.287 | 420.705 | 203.673 | 421.491 | 505.36 | 203.254 | 43.085 |
| Net Income Ratio
| 0.153 | 0.169 | 0.174 | 0.176 | 0.146 | 0.158 | 0.171 | 0.159 | 0.115 | 0.134 | 0.137 | 0.134 | 0.136 | 0.14 | 0.165 | 0.196 | 0.205 | 0.281 | 0.166 | 0.229 | 0.122 | 0.155 | 0.205 | 0.139 | 0.121 | 0.131 | 0.118 | 0.115 | 0.072 | 0.138 | 0.167 | 0.089 | 0.023 |
| EPS
| 9.36 | 10.46 | 11.24 | 11.39 | 8.22 | 8.62 | 9.72 | 9.2 | 5.66 | 6.86 | 14.26 | 13.56 | 10.97 | 10.85 | 12.65 | 15.38 | 13.02 | 19.94 | 9.55 | 15.45 | 6.49 | 8.26 | 11.67 | 7.73 | 6.04 | 6.07 | 6.14 | 5.46 | 2.32 | 4.68 | 5.95 | 2.4 | 0.51 |
| EPS Diluted
| 9.17 | 10.24 | 11 | 11.39 | 8.06 | 8.46 | 9.54 | 9.07 | 5.6 | 6.79 | 14.26 | 13.56 | 10.97 | 10.82 | 12.63 | 15.38 | 13.02 | 19.94 | 9.55 | 15.45 | 6.49 | 8.26 | 11.67 | 7.73 | 6.04 | 6.07 | 6.14 | 5.46 | 2.32 | 4.68 | 5.95 | 2.4 | 0.51 |
| EBITDA
| 2,227.6 | 2,625.1 | 2,804.7 | 2,862.6 | 2,147.5 | 2,304.7 | 2,512 | 2,377.4 | 1,682.2 | 1,779 | 1,859.2 | 1,736.5 | 1,270.049 | 1,326.354 | 1,463.856 | 1,766.565 | 1,492.438 | 2,269.457 | 1,184.918 | 1,781.108 | 849.116 | 1,059.758 | 1,187.697 | 1,085.871 | 811.916 | 937.978 | 900.557 | 822.38 | 403.395 | 596.376 | 757.55 | 364.618 | 130.642 |
| EBITDA Ratio
| 0.235 | 0.272 | 0.28 | 0.285 | 0.249 | 0.273 | 0.285 | 0.265 | 0.221 | 0.224 | 0.23 | 0.221 | 0.203 | 0.221 | 0.247 | 0.292 | 0.303 | 0.414 | 0.267 | 0.341 | 0.206 | 0.247 | 0.26 | 0.243 | 0.21 | 0.246 | 0.207 | 0.225 | 0.142 | 0.195 | 0.25 | 0.159 | 0.071 |